Francine Siegfried

PHD Doctor of Philosophy,  Cleveland Clinic 

Location: United States

Consulting Services

Data Science-Bioinformatics Research Consulting

Areas Of Interest

v-src Gene Process, Genetic Countries, Least Developed Spinocerebellar Ataxias, Dominantly Inherited Ivemark Syndrome Watson-Miller syndrome Coumadin Paraplegia, Cerebral Fitzgerald Factor Heat Stable Enterotoxin Receptor Transcription Factors, TFIII Fold, Synovial Prostatic Cancer, Androgen Independent Evaluation, Disability Wellness Program Paralysis, Peripheral Facial Transfusion Associated Circulatory Overload Vasopressin, Phenylalanine Lysine Lavage Fluid, Bronchial Dilution Techniques, Dye Myelomonocytic Leukemias, Juvenile Amino Terminal Amino Acid Acetylating Enzymes Censuses

Professional Narrative

Dr. Francine Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Mayo Clinic 1990
Executive Director, Harvard Med 2006

Education

Master of Science in physician assistant, Yale School of Medicine 1995
Doctor of medicine, Harvard Medical School 1994

Referees


Publications

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :